Literature DB >> 28302504

Mitochondrial NUDIX hydrolases: A metabolic link between NAD catabolism, GTP and mitochondrial dynamics.

Aaron Long1, Nina Klimova2, Tibor Kristian3.   

Abstract

NAD+ catabolism and mitochondrial dynamics are important parts of normal mitochondrial function and are both reported to be disrupted in aging, neurodegenerative diseases, and acute brain injury. While both processes have been extensively studied there has been little reported on how the mechanisms of these two processes are linked. This review focuses on how downstream NAD+ catabolism via NUDIX hydrolases affects mitochondrial dynamics under pathologic conditions. Additionally, several potential targets in mitochondrial dysfunction and fragmentation are discussed, including the roles of mitochondrial poly(ADP-ribose) polymerase 1(mtPARP1), AMPK, AMP, and intra-mitochondrial GTP metabolism. Mitochondrial and cytosolic NUDIX hydrolases (NUDT9α and NUDT9β) can affect mitochondrial and cellular AMP levels by hydrolyzing ADP- ribose (ADPr) and subsequently altering the levels of GTP and ATP. Poly (ADP-ribose) polymerase 1 (PARP1) is activated after DNA damage, which depletes NAD+ pools and results in the PARylation of nuclear and mitochondrial proteins. In the mitochondria, ADP-ribosyl hydrolase-3 (ARH3) hydrolyzes PAR to ADPr, while NUDT9α metabolizes ADPr to AMP. Elevated AMP levels have been reported to reduce mitochondrial ATP production by inhibiting the adenine nucleotide translocase (ANT), allosterically activating AMPK by altering the cellular AMP: ATP ratio, and by depleting mitochondrial GTP pools by being phosphorylated by adenylate kinase 3 (AK3), which uses GTP as a phosphate donor. Recently, activated AMPK was reported to phosphorylate mitochondria fission factor (MFF), which increases Drp1 localization to the mitochondria and promotes mitochondrial fission. Moreover, the increased AK3 activity could deplete mitochondrial GTP pools and possibly inhibit normal activity of GTP-dependent fusion enzymes, thus altering mitochondrial dynamics. Published by Elsevier Ltd.

Entities:  

Keywords:  AMP; GTP; Mitochondrial dynamics; NAD(+); NUDIX; PARP1

Mesh:

Substances:

Year:  2017        PMID: 28302504     DOI: 10.1016/j.neuint.2017.03.009

Source DB:  PubMed          Journal:  Neurochem Int        ISSN: 0197-0186            Impact factor:   3.921


  7 in total

Review 1.  Emerging roles of ADP-ribosyl-acceptor hydrolases (ARHs) in tumorigenesis and cell death pathways.

Authors:  Xiangning Bu; Jiro Kato; Joel Moss
Journal:  Biochem Pharmacol       Date:  2018-09-27       Impact factor: 5.858

Review 2.  The chemistry of the vitamin B3 metabolome.

Authors:  Mikhail V Makarov; Samuel A J Trammell; Marie E Migaud
Journal:  Biochem Soc Trans       Date:  2018-12-17       Impact factor: 5.407

Review 3.  Nociceptive Roles of TRPM2 Ion Channel in Pathologic Pain.

Authors:  Yongwoo Jang; Pyung Sun Cho; Young Duk Yang; Sun Wook Hwang
Journal:  Mol Neurobiol       Date:  2018-01-11       Impact factor: 5.590

Review 4.  Kynurenine pathway, NAD+ synthesis, and mitochondrial function: Targeting tryptophan metabolism to promote longevity and healthspan.

Authors:  Raul Castro-Portuguez; George L Sutphin
Journal:  Exp Gerontol       Date:  2020-01-16       Impact factor: 4.032

5.  Mouse Nudt13 is a Mitochondrial Nudix Hydrolase with NAD(P)H Pyrophosphohydrolase Activity.

Authors:  Salama R Abdelraheim; David G Spiller; Alexander G McLennan
Journal:  Protein J       Date:  2017-10       Impact factor: 2.371

6.  Mitochondrial Fission Factor Is a Novel Interacting Protein of the Critical B Cell Survival Regulator TRAF3 in B Lymphocytes.

Authors:  Yingying Liu; Samantha Gokhale; Jaeyong Jung; Sining Zhu; Chang Luo; Debanjan Saha; Jessie Yanxiang Guo; Huaye Zhang; Saw Kyin; Wei-Xing Zong; Eileen White; Ping Xie
Journal:  Front Immunol       Date:  2021-10-20       Impact factor: 8.786

7.  Nicotinamide adenine dinucleotide is transported into mammalian mitochondria.

Authors:  Antonio Davila; Ling Liu; Karthikeyani Chellappa; Philip Redpath; Eiko Nakamaru-Ogiso; Lauren M Paolella; Zhigang Zhang; Marie E Migaud; Joshua D Rabinowitz; Joseph A Baur
Journal:  Elife       Date:  2018-06-12       Impact factor: 8.140

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.